Portable Sanitation Association International

July 3 PDF

Issue link: http://psai.uberflip.com/i/1138834

Contents of this Issue

Navigation

Page 10 of 17

W EEKLY EDITION JUNE 19, 2019 Pharmaceuticals in Wastewater: Implications for the Portable Sanitation Industry By Karleen Kos, PSAI Executive Director In 2014 the US Environmental Protection Agency (EPA) published the largest study to that date on this topic. They analyzed wastewater from 50 treatment plants across the US for the presenc e of 54 different active pharmaceutical ingredients. The findings continued to suggest that drug concentrations were low enough to make the water safe to drink, but the data was less clear about its impact on the ecosystem. Later observations noted changes in fish behavior, bugs, and other aquatic species. In February of 2017 the Arabian Journal of Chemistry published an extensive paper analyzing the presence of pharmaceuti cals in wastewater in a city of about 1.1 million in Saudi Arabia. The scientists' extensive study found: The removal efficiency of pharmaceuticals from wastewater is actually dependent on several factors including the climatic conditions, the type of was tewater treatment and its operational conditions (e.g. temperature, redox conditions, solids and hydraulic retention time) as well as the age of the activated sludge used in the plant, but the main factor is reported to be the physico - chemical nature of mo st pharmaceuticals, which is the acidity and high solubility in water with very low solid – liquid partition. […] […S]ome of the pharmaceuticals that were detected in the wastewater were also found in the sludge of the wastewater treatment plants. This is du e to the low solubility of such drugs. […] When considering a single pharmaceutical at low concentrations such as those reported in this investigation and other work, it may be assumed that not many health risks can be associated with long - term exposure t o such a drug. But the health risks associated with exposure to a large number of pharmaceuticals, their metabolites, and transformation products, even at low concentrations, cannot be ignored. Then, in April 2018 the European Monitoring Centre for Drugs and Drug Addiction released data gathered in 2016 showing the presence of cocaine residue in the water supply in several European cities. While monito ring of wastewater for illicit drugs is something they do regularly to determine the amount of illicit drug use, it is a further reminder that the water supply contains pharmaceuticals of all types that both need to be removed through treatment and which r emain in trace amounts that can affect people over time. P AGE 11 CONTINUED ON PAGE 1 2

Articles in this issue

Links on this page

view archives of Portable Sanitation Association International - July 3 PDF